Catalog No.
DHB94429
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Human
Isotype
IgG1-Fc
Clonality
Monoclonal
Target
TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a, TNF-alpha, Tumor necrosis factor, TNFSF2, TNFA, Cachectin, ICD1
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P01375
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
CAS: 185243-69-0
Clone ID
Etanercept
Etanercept for the treatment of rheumatoid arthritis, PMID: 29482402
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis, PMID: 30411183
Etanercept biosimilar SB-4, PMID: 30616405
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial, PMID: 30747501
[Etanercept], PMID: 31204122
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission, PMID: 33205906
GP2015: An Etanercept Biosimilar, PMID: 28940172
Etanercept-induced palisaded neutrophilic granulomatous dermatitis, PMID: 33279312
Etanercept for treating axial spondyloarthritis, PMID: 28682112
Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases, PMID: 27455991
Safety update of etanercept treatment for moderate to severe plaque psoriasis, PMID: 32178543
Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization, PMID: 33043386
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial, PMID: 31122296
Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review, PMID: 32700773
Etanercept in the treatment of psoriatic arthritis, PMID: 25455504
The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study, PMID: 28448562
Etanercept for the treatment of non-radiographic axial spondyloarthritis, PMID: 26788837
Etanercept for Treatment of Taxane-Induced Pneumonitis, PMID: 31219735
Erythromycin-induced pemphigus foliaceus successfully treated with etanercept, PMID: 32808715
The EGALITY study: a confirmatory, randomized, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis, PMID: 27787890
Intra-articular injection of etanercept versus glucocorticoids in rheumatoid arthritis patients, PMID: 32623650
[Etanercept-induced subacute thyroiditis. Case report and literature review], PMID: 28942661
Treatment of psoriasis with etanercept: the typical patient profile, PMID: 27073046
Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats, PMID: 32720159
Etanercept as Adjunctive Primary Therapy in Kawasaki Disease, PMID: 31048416
Efficacy and safety of etanercept in the treatment of sciatica: A systematic review and meta-analysis, PMID: 28779960
Etanercept improves aging-induced cognitive deficits by reducing inflammation and vascular dysfunction in rats, PMID: 32569601
Etanercept combined with systemic drugs or phototherapy for treatment of psoriasis, PMID: 25529463
Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry, PMID: 33121528
Functional analysis of glycosylation in Etanercept: Effects over potency and stability, PMID: 32682933
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis, PMID: 28837372
TNF-α modulation via Etanercept restores bone regeneration of atrophic non-unions, PMID: 32745691
Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation, PMID: 32194205
Etanercept for Ankylosing Spondylitis With Coexisting Demyelinating Myelitis, PMID: 30199382
Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database, PMID: 26618553
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients, PMID: 30610544
A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature, PMID: 27765165
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up, PMID: 30300358
Can etanercept treatment failure in moderate-to-severe psoriasis be overcome by addition of low-dose methotrexate? A single-center experience, PMID: 29466892
Use of Etanercept for Psoriasis in a Renal Transplant Recipient, PMID: 31627849
Efficacy of etanercept for treating the active rheumatoid arthritis: an updated meta-analysis, PMID: 26354025
Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis, PMID: 28750567
Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case, PMID: 31309782
[Actual treatments of psoriasis : from etanercept to anti-IL17 and anti-IL23 antagonists], PMID: 32496683
Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease, PMID: 32347889
Prophylactic etanercept treatment in cisplatin ototoxicity, PMID: 28730299
Oxaliplatin-Induced Rather Than Taxane-Induced Pneumonitis Was Responsive to Etanercept, PMID: 31682545
Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID-19 pandemic: The real-world experience of a single center, PMID: 33274541
Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars, PMID: 31925703
A successful case of etanercept used for idiopathic granulomatous mastitis, PMID: 30790374
For research use only. Not for human or drug use.
